Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™,

First Page		Document Content
Date: 2014-10-22 02:50:49 Percutaneous aortic valve replacement Torso Medicine Human body Edwards Lifesciences Aortic valve Tavi Cardiology Cardiac surgery Aorta John G. Webb		Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, Add to Reading List Source URL: www.biomedvc.com Download Document from Source Website File Size: 198,45 KB Share Document on Facebook

	Late-Breaking Clinical Trial Abstracts Monday, January 30, 2012 1:30 pm – 3:30 pm Do Blood Transfusions Affect the Risk of Infections After Cardiac Surgery? Experience of the NIH/CIHR Cardiothoracic Surgical Trials Net DocID: 1uYJ7 - View Document
	European Journal of Cardio-thoracic Surgery±710 www.elsevier.com/locate/ejcts Intra-institutional prediction of outcome after cardiac surgery: comparison between a locally derived model and the EuroSCORE DocID: 1usbh - View Document
	Scientific Program 17th European Heart Disease & Heart Failure Congress and 2nd International Conference on Cardiovascular Medicine & Cardiac Surgery DocID: 1uoeO - View Document
	Economic Impact of Healthcare-Associated Infections in Cardiac Surgery G Greco, W Shi, RE Michler, EH Blackstone, IL Kron, E Moquete, YJ Woo, AJ Moskowitz, VH Thourani, AM Gillinov, AC Gelijns, M Argenziano, JH Alexander DocID: 1ujLb - View Document
	European Journal of Cardio-thoracic Surgery±399 www.elsevier.com/locate/ejcts Coronary surgery in Europe: comparison of the national subsets of the European System for Cardiac Operative Risk Evaluation dat DocID: 1u3AG - View Document